Navigation Links
Tute Genomics Raises $1.5M for Cloud-based Genome Analytics & Machine-learning for Gene Discovery
Date:12/31/2013

SALT LAKE CITY, Dec. 31, 2013 /PRNewswire-iReach/ -- Tute Genomics announced that it has raised $1.5 million in Seed Round funding to further develop its advanced genome analysis software, allowing researchers to rapidly discover novel disease genes & identify predictive biomarkers. Investors in this round include Wilmington Pharmatech, Salt Lake Life Sciences Angels, Peak Ventures, Park City Angel Network, and a number of individual angel investors. Tute Genomics participated in the BoomStartup accelerator program in Utah this year, and subsequently raised the most funds of any company in BoomStartup's history. Additionally, Tute raised approximately $300K from AngelList, via their new Syndicate mechanism.

(Photo: http://photos.prnewswire.com/prnh/20131231/MN39256)

"The cost of sequencing the human genome has dropped significantly in recent years, making it possible for whole genomes and exomes to be used in both clinical and research settings," says Reid J. Robison, MD MBA, a physician turned data-scientist and CEO of Tute Genomics. "However, data analysis remains as the major hurdle before widespread adoption and individualized medicine can become a reality." Tute's cloud-based genome interpretation platform is derived from the expertise underlying the ANNOVAR technology, one of the gold standards in genome annotation & interpretation. ANNOVAR, written by Tute Genomics President Dr. Kai Wang, has been cited by over 500 scientific publications, and has been used in more gene discovery studies than any other platform.  Building on this foundation, Tute now includes over 90 annotation types, scoring methods and genetic databases, and through an innovative cloud-computing pipeline, lets healthcare & research organizations interpret an entire human genome in less than 15 minutes, and a whole exome in less than 5 minutes. Tute also applies robust statistical models, allowing researchers to conduct large-scale case-control and family-based studies using whole genomes and exomes. Tute Genomics software uses proprietary machine-learning algorithms to rapidly prioritize clinically relevant genetic variants, genes and pathways resulting in improved performance of disease gene & biomarker discovery efforts.

Tute has over 100 registered users across a number of research and clinical institutions, including academic medical centers, CLIA labs and pharma/biotech companies, and has analyzed over 500 genomes since its launch in October 2013. With this successful round of funding, Tute Genomics is opening a new door for personalized medicine by enabling researchers and clinicians to utilize human genome data for scientific discovery and individualized treatment.

Media Contact: Lynn Dakoulas-Dobias, Tute Genomics, 801-710-4035, lynn@tutegenomics.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 


'/>"/>
SOURCE Tute Genomics
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
2. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
3. Rubicon Genomics and Agendia Sign Agreement for Use of TransPLEX® Whole Genome RNA Amplification Technology With Symphony™ Cancer Diagnostics
4. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
5. Rosetta Genomics Pays Off Secured Loan and Reclaims Unencumbered Rights to All Assets
6. First Plant Genomics Yield Technology Progresses
7. Rosetta Genomics Announces Closing of Public Offering of 5.5 Million Ordinary Shares
8. Rosetta Genomics Receives 2012 North American Entrepreneurial Company of the Year Award by Frost & Sullivan
9. Rosetta Genomics Expands Management Team, Laboratory Capacities and Commercial Operations
10. Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics: Twease.org
11. Synthetic Genomics Inc. Purchases Patent Portfolio from Febit Holding GmbH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... While things have ... to restructure the company and provide a new outlook for the future. As ... to implement new management with the retirement of Mr. Siegel as CEO. With the ...
(Date:4/27/2017)... SILVER SPRING, Md. and RESEARCH ... -- United Therapeutics Corporation (NASDAQ: UTHR ) ... repurchase of up to $250 million of the company,s ... will remain open through December 31, 2017. Purchases may ... or in privately negotiated transactions from time to time ...
(Date:4/27/2017)... ... April 27, 2017 , ... Proscia ... their digital pathology technology has the potential to eliminate subjectivity in the detection ... The Netherlands as part of the 2017 ISBI CAMELYON Digital Pathology Challenge, ...
(Date:4/27/2017)... , ... April 27, 2017 , ... ... and secure electronic informed consent (eConsent) solution that simplifies research studies, accelerates study ... consulting division of Quorum, Q Consent™ is the first and only IRB-integrated ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/4/2017)... 2017   EyeLock LLC , a leader of ... States Patent and Trademark Office (USPTO) has issued U.S. ... of an iris image with a face image acquired ... company,s 45 th issued patent. ... given the multi-modal biometric capabilities that have recently come ...
Breaking Biology News(10 mins):